Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of USANA Health Sciences (NYSE: USNA ) were looking stronger today, gaining as much as 10% after the company beat earnings estimates in its quarterly report.
So what: The nutritional and personal-care products maker said earnings per share jumped 42% to $1.28, ahead of the analyst consensus at $1.12. Management reported a 9.7% increase in sales to $169.1 million and a decrease in associate incentive payouts -- which came from a change in the employee matching program -- helped drive the strong earnings growth. An aggressive share buyback program also helped lift per-share profits as the number of shares outstanding decreased by nearly 10% from a year ago.
Now what: Revenue actually missed analyst estimates, but the market seemed to be ignoring that as USANA also raised its EPS guidance for the year to $5.25-$5.40 from $5.10-$5.25, roughly the amount of its earnings beat this quarter. Its new EPS guidance is ahead of analyst estimates at $5.18, but the midpoint of revenue guidance, which was kept at $700 million to $720 million is slightly below the Street's view at $714 million. Considering, the bulk of today's EPS growth came from buybacks and the change in the matching program, I see little reason to change your investing thesis, or in the company's prospects. Shares seem fairly priced after today's jump.
While you can certainly make huge gains in healthcare companies like USANA, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
Don't miss the next dose of USANA news. Add the company to your watchlist to get all the latest updates.
No comments:
Post a Comment